Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery

by palligoelme@gmail.com | Aug 27, 2025 | Clinical Trials

​ Conditions: Colorectal Cancer Interventions: Biological: Lactobacillus casei Shirota; Biological: Lactobacillus acidophilus Sponsors: Dharmais National Cancer Center Hospital Completed Conditions: Colorectal Cancer Interventions: Biological: Lactobacillus casei...

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

by palligoelme@gmail.com | Aug 27, 2025 | Clinical Trials

​ Conditions: Venous Thromboembolism (VTE); Exercise Therapy; Quality of Life (QOL); Anxiety Depression; Humans; Exercise Tolerance; Rehabilitation Exercise; Dyspnea; Functional Status; Pulmonary Embolism (Diagnosis) Interventions: Other: Exercise-based rehabilitation...

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

by palligoelme@gmail.com | Aug 27, 2025 | Clinical Trials

​ Conditions: Intraprostatic Prostate Cancer Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT); Drug: Androgen Deprivation Therapy (ADT) Sponsors: NYU Langone Health Recruiting Conditions: Intraprostatic Prostate Cancer Interventions: Radiation:...

Feasibility of Adding a Plant-Based Protein Pudding to the Diet of Older Adults Who Attend a Medically Managed Fitness Facility

by palligoelme@gmail.com | Aug 27, 2025 | Clinical Trials

​ Conditions: Feasibility Studies; Nutrition Intervention Interventions: Dietary Supplement: Plant Based pudding Sponsors: Seven Oaks Hospital Chronic Disease Innovation Centre Not yet recruiting Conditions: Feasibility Studies; Nutrition Intervention Interventions:...

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

by palligoelme@gmail.com | Aug 26, 2025 | Clinical Trials

​ Conditions: Advanced/Metastatic Solid Tumors Interventions: Drug: DB-1317 Sponsors: DualityBio Inc. Not yet recruiting Conditions: Advanced/Metastatic Solid Tumors Interventions: Drug: DB-1317 Sponsors: DualityBio Inc. Not yet...